![]() |
Name |
4-Phenyleicosane
|
Molecular Formula | C26H46 | |
IUPAC Name* |
icosan-4-ylbenzene
|
|
SMILES |
CCCCCCCCCCCCCCCCC(CCC)C1=CC=CC=C1
|
|
InChI |
InChI=1S/C26H46/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-18-22-25(21-4-2)26-23-19-17-20-24-26/h17,19-20,23-25H,3-16,18,21-22H2,1-2H3
|
|
InChIKey |
RFNYELHDUBVQMR-UHFFFAOYSA-N
|
|
Synonyms |
icosan-4-ylbenzene; Eicosane, 4-phenyl-; 4-PHENYLEICOSANE; 2400-03-5; Benzene, (1-propylheptadecyl)-; 4-phenylicosane; 4-phenyl-eicosane; NSC123364; (Icosan-4-yl)benzene; (1-Propylheptadecyl)benzene #; DTXSID90870971; NSC 123364; NSC-123364; 5134-83-8
|
|
CAS | 2400-03-5 | |
PubChem CID | 16982 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 358.6 | ALogp: | 12.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 18 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 26 | QED Weighted: | 0.197 |
Caco-2 Permeability: | -4.909 | MDCK Permeability: | 0.00000504 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.095 |
30% Bioavailability (F30%): | 0.989 |
Blood-Brain-Barrier Penetration (BBB): | 0.033 | Plasma Protein Binding (PPB): | 100.15% |
Volume Distribution (VD): | 3.628 | Fu: | 0.57% |
CYP1A2-inhibitor: | 0.09 | CYP1A2-substrate: | 0.178 |
CYP2C19-inhibitor: | 0.248 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.077 | CYP2C9-substrate: | 0.97 |
CYP2D6-inhibitor: | 0.042 | CYP2D6-substrate: | 0.055 |
CYP3A4-inhibitor: | 0.258 | CYP3A4-substrate: | 0.101 |
Clearance (CL): | 4.613 | Half-life (T1/2): | 0.013 |
hERG Blockers: | 0.275 | Human Hepatotoxicity (H-HT): | 0.016 |
Drug-inuced Liver Injury (DILI): | 0.093 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.048 | Maximum Recommended Daily Dose: | 0.109 |
Skin Sensitization: | 0.966 | Carcinogencity: | 0.024 |
Eye Corrosion: | 0.939 | Eye Irritation: | 0.982 |
Respiratory Toxicity: | 0.111 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001335 | ![]() |
0.607 | D00AOJ | ![]() |
0.474 | ||
ENC000427 | ![]() |
0.603 | D07ILQ | ![]() |
0.462 | ||
ENC000400 | ![]() |
0.600 | D00FGR | ![]() |
0.452 | ||
ENC000626 | ![]() |
0.600 | D0OR6A | ![]() |
0.414 | ||
ENC000428 | ![]() |
0.598 | D0Z5SM | ![]() |
0.413 | ||
ENC000488 | ![]() |
0.585 | D0P1RL | ![]() |
0.400 | ||
ENC000666 | ![]() |
0.581 | D0T9TJ | ![]() |
0.370 | ||
ENC001124 | ![]() |
0.581 | D00STJ | ![]() |
0.357 | ||
ENC000285 | ![]() |
0.576 | D0O1PH | ![]() |
0.352 | ||
ENC001180 | ![]() |
0.576 | D05ATI | ![]() |
0.352 |